结论CD 105可以作为新生血管的标记物用于抗肿瘤血管形成的研究和治疗。
ConclusionCD105 may be used as a new marker of neovascularization in the research and treatment of anti-tumor angiogenesis.
目的克隆和表达一种新的血管形成抑制因子，并研究其抗肿瘤活性。
Objective A new angiogenesis inhibitor HIAF 1 (human inhibitor angiogenesis factor 1) was cloned, expressed in E.
应用推荐